Hubei Cancer Hospital: Clinical Trials & Research Profile
Hospital / Clinical Site in Wuhan, China · Primary Specialty: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Clinical Trial Research Site |
| Institutional Sector & Location | Hospital / Clinical Site (Wuhan, China) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 150 active (58 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 239 |
| Completed vs Early-Stopped Studies | 48 completed / 17 stopped (7.1% stop rate) |
| Median Closed Enrollment | 344 participants |
| Median Completed Study Duration | 1,526 calendar days |
| Physical Hospital Site Disclosure | 100.0% named hospital campus |
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk